R&D Systems™ Recombinant R. sanguineus Evasin-1 Fc Chimera Protein

Catalog No.	Quantity
10-016-EV050	50 μg

Catalog No. 10-016-EV050 Supplier R&D Systems™ Supplier No. 10016EV050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant R. sanguineus Evasin-1 Fc Chimera Protein is derived from HEK293. The Recombinant R. sanguineus Evasin-1 Fc Chimera Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P0C8E7.1
• For Use With (Application): Bioactivity
• Molecular Weight (g/mol): 37 kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell,HEK293-derived r. sanguineus Evasin-1 protein, (N-terminus) Human IgG1 (Met-Asp-Pro100-Lys330) IEGR R. sanguineus Evasin-1 (Glu21-Asn114) Accession &Num; P0C8E7.1 (C-terminus)
• Storage Requirements: 12 months from date of receipt, <= -20 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU per 1 μg of the protein by the LAL method.
• Specific Reactivity: Evasin-1
• Conjugate: Unconjugated
• Species: R. sanguineus
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS.
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.